Search
for
Sort by
Research 331–360 of 1000+
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Exploring the Complexities of TGF-beta Signaling in Keloids: Beyond the Classical Smad Pathway
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- Transcriptome Dynamics Reveal Stage-Specific and Melatonin-Triggered Gene Expression Patterns During The Cashmere Growth Cycle in Capra Hircus
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Hair today, gone tomorrow
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Vinegar-Processed Black Soybean Promotes Hair Growth and Prevents Alopecia via Wnt/β-Catenin Pathway.
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- What causes hidradenitis suppurativa ?—15 years after
- Emerging treatments in alopecia
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature